Cowen Research Themes 2021 has been published. Click here to learn about the year's key investment themes. >

$150 Million

908 Devices, Inc.

Initial Public Offering

Lead Left Bookrunner, December 2020

908 Devices Inc. has developed an innovative suite of purpose-built handheld and desktop mass spectrometry (“Mass Spec”) devices for the point-of-need. By leveraging its proprietary platform technology and approach, the Company makes the extraordinary analytical power of Mass Spec available in devices that are significantly smaller and more accessible than conventional laboratory instruments. The Company’s Mass Spec devices can be used at the point-of-need to interrogate unknown and invisible materials, and provide quick, actionable answers to directly address critical problems in life sciences research, bioprocessing, industrial biotech, forensics and adjacent markets.

More Like This

Dec 2020
$336 Million

Initial Public Offering and Concurrent Private Placement

Bookrunner

View Details
Nov 2020
$240 Million

Initial Public Offering

Bookrunner

View Details
Oct 2020
$135 Million

Initial Public Offering

Bookrunner

View Details